IGC PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $276.0K | $32.8M | $14.5M |
| FY2022 | $144.0K | $23.9M | $10.5M |
| FY2023 | $141.0K | $14.9M | $3.2M |
| FY2024 | $137.0K | $7.3M | $1.2M |
| FY2025 | $134.0K | $6.3M | $405.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $276.0K | $32.8M | $14.5M |
| FY2022 | $144.0K | $23.9M | $10.5M |
| FY2023 | $141.0K | $14.9M | $3.2M |
| FY2024 | $137.0K | $7.3M | $1.2M |
| FY2025 | $134.0K | $6.3M | $405.0K |